FILTER
FILTERED ARTICLE RESULTS
B.C. Mining Enters an Era of Reconciliation
February 13, 2019
True cohesion between government, Indigenous groups and the sector is the priority.
Metals and Materials of the Future
February 13, 2019
Lithium and vanadium projects are attracting substantial investment.
The Mining Value Chain: 2019 Trends Driving Service Providers
February 05, 2019
Africa’s service providers are rising to the task of providing turnkey solutions and bringing the latest innovations to the continent.
The Delicate Balancing Act of Developing ‘Vogue Minerals’ Projects
February 05, 2019
Expert Opinion Article contributed by SRK Consulting’s global team of consultants.
Turkey’s 21st Century Coal Rush
December 27, 2018
Turkey favors coal development to reach energy self-sufficiency
Toronto’s Financial District
December 27, 2018
Toronto continues to be the investment engine of global mining, despite new competition from cannabis, blockchain and cryptocurrencies.
Safety in Turkish Mines
November 15, 2018
Turkish mining in the dock; recent disasters have cast a dark shadow over Turkish mining.
Prospective Lands: West Africa’s Mining Potential
November 15, 2018
GBR examines the current excitement surrounding the West African mining potential.
The Role of Women in Peru’s Mining Industry
November 06, 2018
by Lita Calenzani, President, Women in Mining Peru (WiM Peru)
Mining 2.0: Sustainable Cash Flows Has New Meaning
November 05, 2018
Dean McPherson defines ‘Mining 2.0’, a new era driven by responsible and innovation-driven mining.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
